BPG is committed to discovery and dissemination of knowledge
Featured Articles
1/15/2016 5:02:00 PM | Browse: 735 | Download: 1927
Publication Name World Journal of Gastrointestinal Oncology
Manuscript ID 20621
Country Italy
ISSN 1948-5204 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Oncology
Manuscript Type Review
Article Title Antitumor effects of the benzophenanthridine alkaloid sanguinarine: Evidence and perspectives
Manuscript Source Invited Manuscript
All Author List Roberta Gaziano, Gabriella Moroni, Cristina Buè, Martino Tony Miele, Paola Sinibaldi-Vallebona and Francesca Pica
Funding Agency and Grant Number
Corresponding Author Francesca Pica, MD, PhD, Department of Experimental Medicine and Surgery, University of Rome Tor Vergata, Via Montpellier, 1, 00133 Rome, Italy. pica@uniroma2.it
Key Words Sanguinarine; Cancer; Apoptosis; Cell-cycle; Chemotherapy
Core Tip Sanguinarine is a benzophenanthridine alkaloid isolated from the root of Sanguinaria canadensis, and other poppy Fumaria species, which exibits a clear-cut anticancer potential by inducing apoptosis and/or antiproliferative effects on tumor cells. Sanguinarine also shows antiangiogenic and anti-invasive properties, as demonstrated in vitro and in vivo. In consideration of the multiple biological effects of sanguinarine, which suggest its possible use in cancer therapy, further detailed pharmacokinetic and toxicologic studies are required to assess both the efficacy and safety of the compound before proposing a possible translation into the clinic.
Publish Date 2016-01-14 20:17
Citation Gaziano R, Moroni G, Buè C, Miele MT, Sinibaldi-Vallebona P, Pica F. Antitumor effects of the benzophenanthridine alkaloid sanguinarine: Evidence and perspectives. World J Gastrointest Oncol 2016; 8(1): 30-39
URL http://www.wjgnet.com/1948-5204/full/v8/i1/30.htm
DOI http://dx.doi.org/10.4251/wjgo.v8.i1.30
Full Article (PDF) WJGO-8-30.pdf
Full Article (Word) WJGO-8-30.doc